ARVN Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $7.41

Capitalizzazione di Mercato (MRQ) $484M

P/E (TTM) 30.9

EPS (TTM) $0.24

Ricavi (TTM) $317M

ROE (TTM) 1.6%

D/E Debito/Patrimonio (MRQ) 0.0

Intervallo 52 sett. $7–$15

ARVN Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Informazioni su Arvinas, Inc. - Common Stock Panoramica della società da Wikipedia

05 · wikidata

Wikidata ↗

settoreHealthcare industriaPharmaceuticals dipendenti246 paeseUS

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$263M

2017-12-31 → 2025-12-31

EPS$-1.14

2019-12-31 → 2025-12-31

Flusso di cassa libero$-276M

2018-12-31 → 2025-12-31

Margine netto2.9%

2018-12-31 → 2025-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	ARVN	media 5 anni	Mediana dei peer	Verdetto
P/E (TTM)	30.9media 5 anni ≈-10.3	≈-10.3	25.1	Sopravvalutato
P/S (TTM)	1.5media 5 anni ≈27.7	≈27.7	2.7	Sottovalutato
P/B (MRQ)	0.9media 5 anni ≈3.4	≈3.4	1.8	Sottovalutato
EV / EBITDA	1.1media 5 anni ≈-4.5	≈-4.5	·	·
Prezzo / FCF (TTM)	-2.3media 5 anni ≈-2.9	≈-2.9	·	·
Prezzo / Flusso di cassa (TTM)	-2.3media 5 anni ≈-3.0	≈-3.0	·	·
EV / Ricavi (TTM)	-0.3media 5 anni ≈15.8	≈15.8	·	·
EV / FCF (TTM)	0.4media 5 anni ≈-0.6	≈-0.6	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	1.3media 5 anni ≈3.4	≈3.4	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	ARVN	media 5 anni	Mediana dei peer	Verdetto
Margine Operativo (TTM)	-5.7%media 5 anni ≈-254.0%	≈-254.0%	-5.3%	Di prim'ordine
EBITDA Margin (Margine EBITDA)	-45.1%media 5 anni ≈-254.0%	≈-254.0%	-1.4%	Di prim'ordine
Margine ante imposte (TTM)	3.2%media 5 anni ≈-190.1%	≈-190.1%	32.3%	Di prim'ordine
Margine di Profitto Netto (TTM)	2.9%media 5 anni ≈-239.6%	≈-239.6%	6.2%	Di prim'ordine
ROA (TTM)	1.2%media 5 anni ≈-18.1%	≈-18.1%	-23.5%	Di prim'ordine
ROE (TTM)	1.6%media 5 anni ≈-37.5%	≈-37.5%	52.3%	Debole
ROIC	-27.4%media 5 anni ≈-45.8%	≈-45.8%	7.1%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	ARVN	media 5 anni	Mediana dei peer	Verdetto
Debito / Patrimonio Netto (MRQ)	0.0media 5 anni ≈0.0	≈0.0	0.0	Debito elevato
Rapporto corrente (MRQ)	7.9media 5 anni ≈4.9	≈4.9	6.2	Liquidità elevata
Quick Ratio (MRQ)	7.5media 5 anni ≈4.8	≈4.8	2.9	Liquidità elevata
Debito a lungo termine / Patrimonio netto (MRQ)	0.0media 5 anni ≈0.0	≈0.0	0.0	Debito elevato

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	ARVN	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)	-0.30%media 5 anni ≈89.4%	≈89.4%	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)	26.0%media 5 anni ≈46.9%	≈46.9%	·	·
Revenue CAGR 5Y (CAGR Ricavi 5Y)	58.9%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	ARVN	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-1.14media 5 anni ≈$-3.93	≈$-3.93	·	·
Revenue / Share (Ricavi / Azione)	$3.70media 5 anni ≈$2.44	≈$2.44	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-3.86media 5 anni ≈$-1.54	≈$-1.54	·	·
Cash / Share (Liquidità / Azione)	$2.25media 5 anni ≈$2.37	≈$2.37	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	ARVN	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)	0.3media 5 anni ≈0.1	≈0.1	0.5	Debole
Receivables Turnover (Rotazione dei crediti)	78.4media 5 anni ≈53.2	≈53.2	3.5	Di prim'ordine
Revenue / Employee (Ricavi / Dipendente)	≈$1.1M	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 163.7%

Prossimo report Nov 03, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 4, 2026	$2.58	$-0.38	784.0%
31 Marzo 2026		$-0.90	$-0.94	4.0%
31 Dicembre 2025		$-1.10	$-0.60	-82.7%
30 Settembre 2025		$-0.48	$-0.81	40.7%
30 Giugno 2025		$-0.84	$-1.02	18.0%
31 Marzo 2025		$1.14	$-0.97	218.1%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 16

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$263M	$263M	$78M	$131M	$54M	$26M	$43M	$14M	$8M
R&D Expense	$285M	$348M	$380M	$315M	$180M	$108M	$67M	$45M	$29M
SG&A Expense	$96M	$165M	$100M	$80M	$62M	$38M	$27M	$13M	$4M
Operating Expenses	$381M	$514M	$480M	$395M	$242M	$147M	$94M	$58M	$32M
Operating Income	$-118M	$-250M	$-402M	$-263M	$-188M	$-121M	$-52M	$-44M	$-25M
Interest Expense	·	$0	$0	$0	$0	$100.0K	$100.0K	$57.4K	$50.4K
Interest Income	$38M	$55M	$39M	$12M	$2M	$4M	$5M	$2M	$201.4K
Other Non-op	$-400.0K	$-3M	$-1M	$200.0K	$2M	$2M	$1M	$102.7K	$554.2K
Pretax Income	$-80M	$-198M	$-364M	$-251M	$-184M	$-115M	·	·	·
Income Tax	$300.0K	$600.0K	$900.0K	$21M	$0	$0	$0	$0	$0
Net Income	$-81M	$-199M	$-367M	$-282M	$-191M	$-119M	$-70M	$-41M	$-24M
EPS (Basic)	$-1.14	$-2.77	$-6.62	$-5.31	$-3.82	$-3.02	$-2.13	·	·
EPS (Diluted)	$-1.14	$-2.77	$-6.62	$-5.31	$-3.82	$-3.02	$-2.13	·	·
Shares (Basic)	70,900,000	71,900,000	55,500,000	53,200,000	50,000,000	39,500,000	32,900,000	·	·
Shares (Diluted)	70,900,000	71,900,000	55,500,000	53,200,000	50,000,000	39,500,000	32,900,000	·	·
EBITDA	$-118M	$-250M	$-402M	$-263M	$-195M	$-125M	$-52M	$-44M	·

Stato Patrimoniale 26

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$143M	$100M	$312M	$81M	$108M	$588M	$9M	$3M	$31M
Short-term Investments	$542M	$939M	$949M	$1.12B	$1.39B	$100M	$272M	$185M	$8M
Receivables	$1M	$6M	$0	$1M	$15M	$1M	·	$3M	$25M
Prepaid Expense	$9M	$14M	$6M	$21M	$20M	$6M	$4M	$3M	$316.9K
Current Assets	$701M	$1.07B	$1.28B	$1.24B	$1.55B	$703M	$291M	$196M	$66M
PP&E (Net)	$5M	$7M	$12M	$13M	$13M	$12M	$8M	$4M	$1M
PP&E (Gross)	$33M	$33M	$33M	$30M	$23M	$18M	$12M	$5M	$2M
Accum. Depreciation	$28M	$26M	$21M	$17M	$11M	$6M	$3M	$2M	$1M
Other Non-current Assets	·	·	·	·	·	$28.8K	$26.8K	$20.8K	·
Total Assets	$718M	$1.09B	$1.30B	$1.27B	$1.58B	$717M	$302M	$199M	$67M
Accounts Payable	$24M	$13M	$18M	$6M	$31M	$7M	$5M	$3M	$596.5K
Accrued Liabilities	·	·	·	·	$23M	$19M	$8M	$4M	$4M
Current Liabilities	$142M	$230M	$257M	$295M	$262M	$49M	$33M	$23M	$18M
Capital Leases	$7M	$7M	$500.0K	$3M	$3M	$1M	$2M	·	·
Other Non-current Liabilities	·	·	·	·	·	·	·	$150.0K	·
Total Liabilities	$284M	$530M	$645M	$704M	$800M	$75M	$75M	$63M	$67M
Long-term Debt	$600.0K	$800.0K	$1M	$1M	$1M	$2M	$2M	$2M	$310.4K
Total Debt	$600.0K	$800.0K	$1M	$1M	$1M	$2M	$2M	$2M	·
Common Stock	$100.0K	$100.0K	$100.0K	$100.0K	$0	$0	$38.5K	$31.2K	·
Paid-in Capital	$2.14B	$2.09B	$2.00B	$1.55B	$1.47B	$1.13B	$599M	$439M	·
Retained Earnings	$-1.61B	$-1.53B	$-1.33B	$-965M	$-683M	$-492M	$-373M	$-302M	$-62M
Treasury Stock	$92M	$0	·	·	·	·	·	·	·
AOCI	$1M	$1M	$-3M	$-19M	$-5M	$600.0K	$107.6K	$-217.7K	$-9.8K
Stockholders' Equity	$434M	$562M	$660M	$565M	$782M	$642M	$227M	$137M	$-61M
Liabilities + Equity	$718M	$1.09B	$1.30B	$1.27B	$1.58B	$717M	$302M	$199M	$67M
Shares Outstanding	63,500,000	68,800,000	68,000,000	53,200,000	53,000,000	48,500,000	38,500,000	31,200,000	·

Flusso di cassa 17

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$3M	$5M	$5M	$6M	$5M	$3M	$2M	$706.0K	$347.4K
Stock-based Comp	$44M	$88M	$72M	$76M	$57M	$30M	$20M	$12M	$245.0K
Deferred Tax	$0	$0	$0	$0	$0	$0	·	·	·
Restructuring	$4M	$0	$0	·	·	·	·	·	·
Operating Cash Flow	$-274M	$-259M	$-348M	$-274M	$559M	$-90M	$-41M	$-16M	$5M
CapEx	$2M	$2M	$3M	$7M	$5M	$6M	$6M	$3M	$1M
Investing Cash Flow	$408M	$35M	$204M	$243M	$-1.31B	$164M	$-93M	$-180M	$21M
Debt Issued	·	·	·	·	·	$0	$0	$2M	$0
Net Debt Issued	$-200.0K	$-400.0K	·	·	$0	$0	$-169.6K	$2M	·
Stock Issued	·	·	·	·	·	·	$138M	$115M	$0
Stock Repurchased	$92M	$0	$0	·	·	·	·	·	·
Net Stock Activity	$-92M	·	·	·	·	·	$138M	$115M	·
Financing Cash Flow	$-91M	$8M	$375M	$5M	$279M	$505M	$140M	$168M	$-161.4K
Net Change in Cash	$42M	$-217M	$230M	$-26M	$-476M	$579M	$6M	$-28M	$26M
Taxes Paid	$-400.0K	$2M	$11M	$11M	$0	$0	·	·	·
Free Cash Flow	$-276M	$-261M	$-351M	$-280M	$555M	$-96M	$-47M	$-19M	·
Levered FCF	·	$-261M	$-351M	·	·	·	·	·	·

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Operating Margin	-45.1%	-95.0%	-511.5%	-200.3%	-418.2%	-572.7%	-119.9%	-305.8%	·
Net Margin	-30.8%	-75.5%	-467.9%	-215.0%	-409.0%	-547.3%	-163.6%	-289.6%	·
Pretax Margin	-30.6%	-75.3%	-463.6%	-191.0%	·	·	·	·	·
EBITDA Margin	-45.1%	-95.0%	-511.5%	-200.3%	-418.2%	-572.7%	-119.9%	-305.8%	·
ROA	-8.9%	-16.6%	-28.5%	-19.8%	-16.6%	-23.4%	-28.1%	-31.2%	·
ROE	-15.5%	-34.7%	-65.8%	-47.6%	-23.9%	-28.2%	-39.0%	58.4%	·
ROIC	-27.4%	-44.6%	-60.9%	-50.4%	·	·	·	·	·

Liquidità e Solvibilità 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	4.9	4.6	5.0	4.2	5.9	14.3	8.9	8.5	·
Quick Ratio	4.8	4.5	4.9	4.1	5.8	14.0	8.6	8.3	·
Debt / Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	·
LT Debt / Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	·
Interest Coverage	·	·	·	·	-1953.0	-1920.9	-602.1	-762.6	·

Efficienza 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover		0.3	0.2	0.1	0.1	0.0	0.0	0.2	0.1	·
Receivables Turnover		78.4	40.5	10.0	131.4	5.5	11.5	·	1.0	·

Per Azione 5

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$6.83	$8.16	$9.71	$10.62	$14.75	$13.25	$5.89	$4.38	·
Revenue / Share	$3.70	$3.66	$1.41	$2.47	$0.93	·	·	·	·
Cash Flow / Share	$-3.86	$-3.61	$-6.27	$-5.14	$11.19	·	·	·	·
Cash / Share	$2.25	$1.46	$4.58	$1.53	$2.04	$12.14	$0.24	$0.10	·
EPS (TTM)	$-1.14	$-2.77	$-6.62	$-5.31	$-3.82	$-3.02	$-2.13	·	·

Tassi di Crescita 3

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-0.30%	235.5%	-40.3%	145.2%	106.9%	·	·	·	·
Revenue CAGR 3Y	26.0%	70.0%	44.7%	·	·	·	·	·	·
Revenue CAGR 5Y	58.9%	·	·	·	·	·	·	·	·

Valutazione (TTM) 14

Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$263M	$263M	$78M	$131M	$54M	$26M	$43M	$14M	·
Net Income TTM	$-81M	$-199M	$-367M	$-282M	$-191M	$-119M	$-70M	$-41M	·
Market Cap	$753M	$1.32B	$2.80B	$1.82B	$4.35B	$4.12B	$1.58B	$401M	·
Enterprise Value	$68M	$280M	$1.54B	$616M	$2.85B	$3.43B	$1.30B	$216M	·
P/E	-10.4	-6.9	-6.2	-6.4	-21.5	-28.1	-19.3	·	·
P/S	2.9	5.0	35.7	13.9	81.2	158.9	36.8	28.0	·
P/B	1.7	2.3	4.2	3.2	5.6	6.4	7.0	2.9	·
P / Tangible Book	1.7	2.3	4.2	3.2	5.6	6.4	·	·	·
P / Cash Flow	-2.8	-5.1	-8.0	-6.7	7.8	-45.8	-38.9	-24.9	·
P / FCF	-2.7	-5.1	-8.0	-6.5	7.8	-42.8	-33.7	-21.2	·
EV / EBITDA	-0.6	-1.1	-3.8	-2.3	-14.6	-27.5	-25.3	-4.9	·
EV / FCF	-0.2	-1.1	-4.4	-2.2	5.1	-35.6	-27.8	-11.4	·
EV / Revenue	0.3	1.1	19.6	4.7	53.2	132.4	30.3	15.1	·
Earnings Yield	-9.6%	-14.4%	-16.1%	-15.5%	-4.7%	-3.6%	-5.2%	·	·

Conto Economico 16

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$250M	$16M	$10M	$42M	$22M	$189M	$59M	$102M	$76M	$25M	$-43M	$35M	$54M	$32M	$38M	$33M
R&D Expense	$53M	$60M	$61M	$65M	$69M	$91M	$83M	$87M	$94M	$84M	$95M	$86M	$103M	$95M	$98M	$78M
SG&A Expense	$24M	$19M	$23M	$21M	$25M	$27M	$34M	$76M	$31M	$24M	$27M	$23M	$26M	$25M	$15M	$20M
Operating Expenses	$86M	$79M	$84M	$86M	$94M	$117M	$117M	$163M	$125M	$109M	$122M	$108M	$129M	$120M	$113M	$98M
Operating Income	$164M	$-64M	$-75M	$-44M	$-72M	$71M	$-58M	$-60M	$-48M	$-83M	$-165M	$-74M	$-75M	$-88M	$-75M	$-64M
Interest Expense	·	·	·	·	$0	$0	·	$0	$0	$0	·	$0	$0	$0	$0	$0
Interest Income	$6M	$6M	$7M	$9M	$10M	$12M	$13M	$14M	$14M	$14M	$12M	$10M	$9M	$8M	$6M	$3M
Other Non-op	$0	$-100.0K	$-12M	$0	$-300.0K	$0	$-14M	$-3M	$-100.0K	$14M	$-100.0K	$0	$0	$-1M	$600.0K	$-200.0K
Pretax Income	$170M	$-58M	$-67M	$-35M	$-62M	$83M	$-45M	$-49M	$-35M	$-69M	$-153M	$-64M	$-66M	$-81M	$-69M	$-61M
Income Tax	$200.0K	$100.0K	$100.0K	$300.0K	$-300.0K	$200.0K	$-300.0K	$600.0K	$200.0K	$100.0K	$2M	$0	$-300.0K	$-400.0K	$11M	$2M
Net Income	$169M	$-58M	$-67M	$-35M	$-61M	$83M	$-45M	$-49M	$-35M	$-69M	$-155M	$-64M	$-67M	$-82M	$-83M	$-66M
EPS (Basic)	$2.61	$-0.90	$-0.96	$-0.48	$-0.84	$1.14	$-0.63	$-0.68	$-0.49	$-0.97	$-2.65	$-1.18	$-1.25	$-1.54	$-1.55	$-1.24
EPS (Diluted)	$2.58	$-0.90	$-0.96	$-0.48	$-0.84	$1.14	$-0.63	$-0.68	$-0.49	$-0.97	$-2.65	$-1.18	$-1.25	$-1.54	$-1.55	$-1.24
Shares (Basic)	64,800,000	64,000,000	·	73,200,000	73,000,000	72,500,000	·	72,100,000	71,900,000	71,700,000	·	54,100,000	53,400,000	53,300,000	·	53,200,000
Shares (Diluted)	65,700,000	64,000,000	·	73,200,000	73,000,000	72,700,000	·	72,100,000	71,900,000	71,700,000	·	54,100,000	53,400,000	53,300,000	·	53,200,000
EBITDA	$164M	$-64M	·	$-44M	$-72M	$71M	·	$-60M	$-48M	$-83M	·	$-74M	$-75M	$-88M	·	$-67M

Stato Patrimoniale 23

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$94M	$87M	$143M	$102M	$115M	$81M	$100M	$85M	$155M	$88M	$312M	$114M	$91M	$130M	$81M	$133M
Short-term Investments	$474M	$528M	$542M	$686M	$746M	$873M	$939M	$1.04B	$1.07B	$1.08B	·	$885M	$948M	$993M	·	$1.14B
Receivables	$50M	$2M	$1M	$20M	$500.0K	$400.0K	$6M	$7M	$2M	$0	$0	$16M	$100.0K	$0	$1M	$1M
Prepaid Expense	$30M	$9M	$9M	$12M	$17M	$17M	$14M	$13M	$12M	$8M	·	$8M	$8M	$14M	·	$22M
Current Assets	$652M	$631M	$701M	$826M	$890M	$980M	$1.07B	$1.15B	$1.26B	$1.19B	·	$1.03B	$1.06B	$1.15B	·	$1.30B
PP&E (Net)	$5M	$6M	$5M	$5M	$6M	$7M	$7M	$7M	$10M	$10M	·	$13M	$13M	$13M	·	$14M
PP&E (Gross)	$34M	$34M	$33M	$33M	$33M	$33M	$33M	$31M	$33M	$33M	·	$33M	$32M	$31M	·	$29M
Accum. Depreciation	$29M	$28M	$28M	$28M	$27M	$26M	$26M	$24M	$23M	$22M	·	$20M	$19M	$18M	·	$15M
Total Assets	$675M	$648M	$718M	$844M	$909M	$1.00B	$1.09B	$1.17B	$1.28B	$1.21B	·	$1.06B	$1.08B	$1.18B	·	$1.33B
Accounts Payable	$8M	$31M	$24M	$18M	$17M	$26M	$13M	$18M	$23M	$18M	·	$34M	$7M	$12M	·	$8M
Current Liabilities	$82M	$116M	$142M	$145M	$158M	$214M	$230M	$276M	$347M	$241M	·	$317M	$307M	$283M	·	$245M
Capital Leases	$6M	$6M	$7M	$7M	$8M	$8M	$7M	$100.0K	$200.0K	$400.0K	·	$1M	$2M	$2M	·	$3M
Total Liabilities	$113M	$261M	$284M	$280M	$300M	$341M	$530M	$581M	$679M	$603M	·	$601M	$620M	$665M	·	$713M
Long-term Debt	$500.0K	$500.0K	$600.0K	$600.0K	$700.0K	$700.0K	$800.0K	$800.0K	$900.0K	$900.0K	·	$1M	$1M	$1M	·	$1M
Total Debt	$500.0K	$500.0K	·	$600.0K	$700.0K	$700.0K	·	$800.0K	$900.0K	$900.0K	·	$1M	$1M	$1M	·	$1M
Common Stock	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	$100.0K	·	$100.0K	$100.0K	$100.0K	·	$100.0K
Paid-in Capital	$2.16B	$2.15B	$2.14B	$2.13B	$2.12B	$2.11B	$2.09B	$2.07B	$2.04B	$2.02B	·	$1.64B	$1.59B	$1.57B	·	$1.53B
Retained Earnings	$-1.50B	$-1.67B	$-1.61B	$-1.54B	$-1.51B	$-1.45B	$-1.53B	$-1.49B	$-1.44B	$-1.40B	·	$-1.18B	$-1.11B	$-1.05B	·	$-882M
Treasury Stock	$92M	$92M	$92M	$20M	·	·	$0	·	·	·	·	·	·	·	·	·
AOCI	$-800.0K	$-400.0K	$1M	$1M	$1M	$2M	$1M	$4M	$-4M	$-4M	·	$-9M	$-12M	$-13M	·	$-25M
Stockholders' Equity	$562M	$387M	$434M	$564M	$609M	$660M	$562M	$586M	$600M	$610M	$660M	$457M	$464M	$511M	$565M	$622M
Liabilities + Equity	$675M	$648M	$718M	$844M	$909M	$1.00B	$1.09B	$1.17B	$1.28B	$1.21B	·	$1.06B	$1.08B	$1.18B	·	$1.33B
Shares Outstanding	65,300,000	64,500,000	63,500,000	70,800,000	73,200,000	73,000,000	68,800,000	68,700,000	68,600,000	68,300,000	68,000,000	55,000,000	53,400,000	53,400,000	53,200,000	53,200,000

Flusso di cassa 13

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$700.0K	$700.0K	$700.0K	$800.0K	$800.0K	$700.0K	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$1M	$2M	$2M
Stock-based Comp	$6M	$12M	$8M	$10M	$10M	$15M	$23M	$25M	$22M	$19M	$17M	$17M	$18M	$20M	$20M	$19M
Restructuring	$2M	$1M	$3M	$-200.0K	$1M	·	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-48M	$-69M	$-30M	$-59M	$-95M	$-89M	$-84M	$-128M	$50M	$-98M	$-83M	$-85M	$-89M	$-91M	$-71M	$-67M
CapEx	$200.0K	$1M	$200.0K	$100.0K	$1M	$400.0K	$300.0K	$700.0K	$700.0K	$100.0K	$100.0K	$1M	$600.0K	$1M	$1M	$2M
Investing Cash Flow	$55M	$14M	$146M	$64M	$129M	$70M	$99M	$50M	$13M	$-128M	$-54M	$70M	$49M	$139M	$19M	$106M
Net Debt Issued	·	$-100.0K	·	·	·	$-100.0K	·	·	·	$-200.0K	·	·	·	·	·	·
Stock Repurchased	·	·	$74M	·	·	·	$0	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$400.0K	$-100.0K	$-74M	$-18M	$500.0K	$-100.0K	$500.0K	$2M	$3M	$2M	$335M	$38M	$500.0K	$2M	$500.0K	$1M
Net Change in Cash	$7M	$-56M	$41M	$-13M	$34M	$-20M	$15M	$-75M	$67M	$-224M	$198M	$23M	$-40M	$49M	$-51M	$40M
Taxes Paid	·	·	$-700.0K	$300.0K	$0	$0	$700.0K	$100.0K	$300.0K	$1M	$2M	$100.0K	$9M	$0	$3M	$8M
Free Cash Flow	·	$-70M	·	·	·	$-89M	·	·	·	$-98M	·	·	·	$-92M	·	·
Levered FCF	·	·	·	·	·	$-89M	·	·	·	$-98M	·	·	·	$-92M	·	·

Redditività 7

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	65.7%	-409.0%	·	-104.5%	-319.2%	37.8%	·	-58.9%	-63.4%	-329.2%	·	-213.6%	-136.9%	-269.9%	·	-221.8%
Net Margin	67.8%	-369.2%	·	-83.8%	-273.2%	43.9%	·	-48.0%	-46.0%	-274.3%	·	-185.0%	-122.2%	-252.0%	·	-218.5%
Pretax Margin	67.9%	-368.6%	·	-83.0%	-274.5%	44.0%	·	-47.5%	-45.8%	-273.9%	·	-184.7%	-120.4%	-249.8%	·	·
EBITDA Margin	65.7%	-409.0%	·	-104.5%	-319.2%	37.8%	·	-58.9%	-63.4%	-329.2%	·	-213.6%	-136.9%	-269.9%	·	-221.8%
ROA	21.4%	-7.0%	·	-3.5%	-5.6%	7.5%	·	-4.4%	-3.0%	-5.8%	·	-5.3%	-5.3%	-6.2%	·	-4.5%
ROE	28.9%	-11.0%	·	-6.1%	-10.1%	13.1%	·	-9.4%	-6.6%	-12.4%	·	-11.9%	-11.7%	-13.3%	·	-9.2%
ROIC	29.1%	-16.5%	·	-7.8%	-11.7%	10.8%	·	-10.4%	-8.1%	-13.7%	·	-16.1%	-16.0%	-17.0%	·	·

Liquidità e Solvibilità 4

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	7.9	5.4	·	5.7	5.6	4.6	·	4.2	3.6	4.9	·	3.3	3.4	4.1	·	5.3
Quick Ratio	7.5	5.3	·	5.6	5.5	4.5	·	4.1	3.5	4.9	·	3.2	3.4	4.0	·	5.2
Debt / Equity	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0
LT Debt / Equity	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0

Efficienza 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.3	0.0	·	0.0	0.0	0.2	·	0.1	0.1	0.0	·	0.0	0.0	0.0	·	0.0
Receivables Turnover		9.8	14.2	·	3.0	19.5	944.0	·	8.9	80.5	·	·	4.1	72.7	·	·	21.0

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$8.61	$6.00	·	$7.97	$8.32	$9.04	·	$8.53	$8.75	$8.93	·	$8.31	$8.68	$9.57	·	$11.68
Revenue / Share	$3.80	$0.24	·	$0.57	$0.31	$2.60	·	$1.42	$1.06	$0.35	·	$0.64	$1.02	$0.61	·	$0.57
Cash Flow / Share	·	$-1.08	·	·	·	$-1.22	·	·	·	$-1.36	·	·	·	$-1.71	·	·
Cash / Share	$1.44	$1.35	·	$1.43	$1.57	$1.11	·	$1.24	$2.26	$1.29	·	$2.07	$1.70	$2.44	·	$2.49
EPS (TTM)	$0.24	$-3.18	·	$-0.81	$-1.01	$-0.66	·	$-4.79	$-5.29	$-6.05	·	$-5.52	$-5.58	$-5.65	·	$-4.77

Valutazione (TTM) 11

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$317M	$89M	·	$312M	$373M	$427M	·	$161M	$93M	$71M	·	$160M	$158M	$137M	·	$127M
Net Income TTM	$9M	$-221M	·	$-58M	$-73M	$-47M	·	$-309M	$-323M	$-355M	·	$-295M	$-298M	$-301M	·	$-252M
Market Cap	$543M	$684M	·	$603M	$539M	$512M	·	$1.69B	$1.83B	$2.82B	·	$1.08B	$1.33B	$1.46B	·	$2.37B
Enterprise Value	$-25M	$69M	·	$-184M	$-322M	$-441M	·	$571M	$598M	$1.65B	·	$83M	$288M	$336M	·	$1.10B
P/E	34.6	-3.3	·	-10.5	-7.3	-10.6	·	-5.1	-5.0	-6.8	·	-3.6	-4.4	-4.8	·	-9.3
P/S	1.7	7.6	·	1.9	1.4	1.2	·	10.5	19.6	39.5	·	6.8	8.4	10.6	·	18.7
P/B	1.0	1.8	·	1.1	0.9	0.8	·	2.9	3.0	4.6	·	2.4	2.9	2.9	·	3.8
P / Tangible Book	1.0	1.8	·	1.1	0.9	0.8	·	2.9	3.0	4.6	·	2.4	2.9	2.9	·	3.8
P / Cash Flow	·	-9.9	·	·	·	-5.8	·	·	·	-28.9	·	·	·	-16.0	·	·
EV / Revenue	-0.1	0.8	·	-0.6	-0.9	-1.0	·	3.5	6.4	23.2	·	0.5	1.8	2.4	·	8.7
Earnings Yield	2.9%	-30.0%	·	-9.5%	-13.7%	-9.4%	·	-19.4%	-19.9%	-14.7%	·	-28.1%	-22.5%	-20.7%	·	-10.7%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$263M	$263M	$78M	$131M	$54M
Margine Operativo %	-45.1%	-95.0%	-511.5%	-200.3%	-418.2%
Utile netto	$-81M	$-199M	$-367M	$-282M	$-191M
EPS Diluito	$-1.14	$-2.77	$-6.62	$-5.31	$-3.82

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debito / Patrimonio Netto	0.0	0.0	0.0	0.0	0.0
Rapporto corrente	4.9	4.6	5.0	4.2	5.9
Quick Ratio	4.8	4.5	4.9	4.1	5.8

Metrica	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-276M	$-261M	$-351M	$-280M	$555M

Proprietari istituzionali (13F) 220 filer · $556.3M totale · Aggiornato al 30 Settembre 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 220

Valore detenuto $556.3M

Nuove posizioni 35

Posizioni chiuse 36

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
35 (0 vs trimestre precedente)	36 (+6 vs trimestre precedente)	79 (+20 vs trimestre precedente)	52 (-22 vs trimestre precedente)	+927K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
VANGUARD GROUP INC	$85.743.091	7.229.603	15,41%	Azioni
BlackRock, Inc.	$63.231.810	7.609.123	11,37%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$34.265.446	4.123.399	6,16%	Azioni
D. E. Shaw & Co., Inc.	$29.044.721	3.495.153	5,22%	Azioni
Pfizer Inc	$27.662.520	3.457.815	4,97%	Azioni
ARMISTICE CAPITAL, LLC	$23.234.760	2.796.000	4,18%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$22.554.695	2.714.163	4,05%	Azioni
TWO SIGMA INVESTMENTS, LP	$21.385.345	2.573.447	3,84%	Azioni
STATE STREET CORP	$18.256.006	2.196.872	3,28%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$13.858.210	1.667.265	2,49%	Azioni
New Leaf Venture Partners, L.L.C.	$13.510.343	1.585.721	2,43%	Azioni
Qube Research & Technologies Ltd	$13.231.814	1.592.276	2,38%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$11.739.063	1.412.643	2,11%	Azioni
FEDERATED HERMES, INC.	$11.268.626	1.356.032	2,03%	Azioni
TWO SIGMA ADVISERS, LP	$7.352.014	619.900	1,32%	Azioni
Hillsdale Investment Management Inc.	$6.239.979	750.900	1,12%	Azioni
TCG Crossover Management, LLC	$5.875.984	707.098	1,06%	Azioni
DIMENSIONAL FUND ADVISORS LP	$5.442.156	654.909	0,98%	Azioni
GOLDMAN SACHS GROUP INC	$5.325.139	640.811	0,96%	Azioni
CITADEL ADVISORS LLC	$5.160.286	620.973	0,93%	Azioni
NORTHERN TRUST CORP	$5.113.110	615.296	0,92%	Azioni
AQR CAPITAL MANAGEMENT LLC	$5.001.565	601.873	0,90%	Azioni
KENNEDY CAPITAL MANAGEMENT LLC	$4.896.568	589.238	0,88%	Azioni
MILLENNIUM MANAGEMENT LLC	$4.770.031	574.011	0,86%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$4.505.466	542.174	0,81%	Azioni
MORGAN STANLEY	$4.177.897	502.755	0,75%	Azioni
NORDEA INVESTMENT MANAGEMENT AB	$3.985.761	476.196	0,72%	Azioni
UBS Group AG	$3.695.241	444.674	0,66%	Azioni
VANGUARD FIDUCIARY TRUST CO	$3.550.231	427.224	0,64%	Azioni
ALGERT GLOBAL LLC	$3.543.509	426.415	0,64%	Azioni
FRANKLIN RESOURCES INC	$3.044.975	366.423	0,55%	Azioni
FMR LLC	$3.034.862	365.206	0,55%	Azioni
WASATCH ADVISORS LP	$2.987.684	281.857	0,54%	Azioni
Ikarian Capital, LLC	$2.977.115	358.257	0,54%	Azioni
Nextech Invest Ltd.	$2.964.285	356.713	0,53%	Azioni
Aquilo Capital Management, LLC	$2.532.577	360.766	0,46%	Azioni
Nantahala Capital Management, LLC	$2.493.000	300.000	0,45%	Azioni
Jump Financial, LLC	$2.461.156	296.168	0,44%	Azioni
Arbiter Partners Capital Management LLC	$2.448.076	294.594	0,44%	Azioni
Man Group plc	$2.128.224	256.104	0,38%	Azioni
Bank of New York Mellon Corp	$2.119.021	254.997	0,38%	Azioni
BANK OF AMERICA CORP /DE/	$2.101.923	252.939	0,38%	Azioni
Invesco Ltd.	$2.060.216	247.920	0,37%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$1.789.517	215.345	0,32%	Azioni
Squarepoint Ops LLC	$1.677.141	201.822	0,30%	Azioni
Cubist Systematic Strategies, LLC	$1.598.724	187.643	0,29%	Azioni
AMERIPRISE FINANCIAL INC	$1.540.234	185.347	0,28%	Azioni
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$1.496.000	180.000	0,27%	Azioni
Rangeley Capital, LLC	$1.459.153	175.590	0,26%	Azioni
Connor, Clark & Lunn Investment Management Ltd.	$1.388.235	167.056	0,25%	Azioni

Mostra tutti i 220 proprietari istituzionali →

Attivisti e proprietari del 5%+ 1 partecipazione

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Logos Global Management LP, Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC, Logos Opportunities Fund IV GP LLC, Logos Opportunities Fund IV LP, Arsani William, Graham Walmsley ×3 depositi	15 Ottobre 2025	3,40%	Modifica	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 25 insider · 9 dirigenti · 16 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Acquisti 12m	Vendite 12m	Netto 12m
Randy Teel	President and CEO	21 Maggio 2026 S	285.009	0	5	$-226.510
Andrew Saik	Chief Financial Officer	24 Giugno 2026 S	187.432	0	3	$-218.244
Sean A Cassidy	Chief Financial Officer	23 Febbraio 2024 S	181.916	0	0	$0
Ian Taylor	President, R&D	24 Febbraio 2025 S	159.121	0	0	$0
Angela M Cacace	Chief Scientific Officer	17 Giugno 2026 S	180.390	0	5	$-214.053
David K Loomis	VP, Chief Accounting Officer	11 Maggio 2026 S	40.193	0	4	$-46.903
Noah Berkowitz	Chief Medical Officer	11 Maggio 2026 S	191.395	0	3	$-249.437
Ronald Peck	Chief Medical Officer	23 Febbraio 2024 A	67.516	0	0	$0
Andrew Crew	Senior Vice President, Chemistry	01 Marzo 2019 A	·	0	0	$0
Edward Moore Kennedy Jr.	Direttore	24 Giugno 2026 A	54.957	0	0	$0
Briggs Morrison	Direttore	24 Giugno 2026 A	111.548	1	0	$268.000
Alsup Laurie Smaldone	Direttore	24 Giugno 2026 A	41.572	0	0	$0
Linda Bain	Direttore	24 Giugno 2026 A	41.572	0	0	$0
Everett Cunningham	Direttore	24 Giugno 2026 A	41.572	0	0	$0
Leslie V Norwalk	Direttore	24 Giugno 2026 A	41.572	0	0	$0
John G Houston	Direttore	27 Febbraio 2026 S	1.122.183	0	3	$-466.153
Sunil Agarwal	Direttore	25 Giugno 2025 A	30.166	0	0	$0
John D Young	Direttore	25 Giugno 2025 A	26.045	0	0	$0
Wendy L Dixon	Direttore	15 Giugno 2023 A	9.121	0	0	$0
Bradley Albert Margus	Direttore	16 Giugno 2022 A	2.000	0	0	$0
Liam Ratcliffe	Direttore	16 Giugno 2022 A	185.686	0	0	$0
Timothy M Shannon	Direttore	16 Giugno 2022 A	1.653.128	0	0	$0
Jakob Loven	Direttore	03 Giugno 2020 A	1.694.351	0	0	$0
Kush Parmar	Direttore	24 Settembre 2019 G	1.775	0	0	$0
Craig Martin Crews	Proprietario del 10%	26 Settembre 2018 J	·	0	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 30 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
PILL · Direxion Shares ETF Trust	0,90%	23.099 NS	31 Luglio 2026	N-PORT
BBC · ETFis Series Trust I	0,71%	41.004 NS	31 Luglio 2026	N-PORT
QQQS · Invesco Exchange-Traded Fund Trust …	0,44%	13.041 SH	01 Ottobre 2026	Giornaliero
IHE · iShares Trust	0,13%	239.280 SH	11 Settembre 2026	Giornaliero
ESSC · Strategy Shares	0,11%	4.749 NS	31 Luglio 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,04%	152.360 SH	01 Ottobre 2026	Giornaliero
IBB · iShares Trust	0,04%	420.421 SH	11 Settembre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,03%	4.637 SH	01 Ottobre 2026	Giornaliero
VTWV · VANGUARD SCOTTSDALE FUNDS	0,03%	46.763 SH	19 Agosto 2026	Giornaliero
IWM · iShares Trust	0,02%	1.521.983 SH	11 Settembre 2026	Giornaliero
PKW · Invesco Exchange-Traded Fund Trust	0,02%	33.358 SH	01 Ottobre 2026	Giornaliero
RSSL · Global X Funds	0,02%	28.418 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	727.130 SH	19 Agosto 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,01%	341.952 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,01%	163.348 SH	19 Agosto 2026	Giornaliero
FHLC · FIDELITY COVINGTON TRUST	0,01%	25.787 NS	31 Luglio 2026	N-PORT
WSML · iShares Trust	0,01%	3.979 SH	10 Settembre 2026	Giornaliero
DXUV · Dimensional ETF Trust	0,00%	2.431 NS	31 Luglio 2026	N-PORT
IWO · iShares Trust	0,00%	47.224 SH	11 Settembre 2026	Giornaliero
DCOR · Dimensional ETF Trust	0,00%	7.928 NS	31 Luglio 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	71.348 NS	31 Luglio 2026	N-PORT
ITOT · iShares Trust	0,00%	95.471 SH	11 Settembre 2026	Giornaliero
DFAU · Dimensional ETF Trust	0,00%	14.344 NS	31 Luglio 2026	N-PORT
IWV · iShares Trust	0,00%	14.933 SH	10 Settembre 2026	Giornaliero
DFUS · Dimensional ETF Trust	0,00%	13.543 NS	31 Luglio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	6.292 NS	31 Luglio 2026	N-PORT
VTI · VANGUARD INDEX FUNDS	0,00%	1.920.682 SH	19 Agosto 2026	Giornaliero
VTWG · VANGUARD SCOTTSDALE FUNDS	0,00%	6.113 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	4.186 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	504.021 SH	11 Settembre 2026	Giornaliero

ARVN Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 23 analisti COMPRA

Target mediano $13.00 +75,4%

4 17,4% Acquisto forte

9 39,1% Compra

9 39,1% Mantieni

1 4,3% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

14 analisti · 2026-09-30

Target medio $13.93 +88,0%

Ora Prezzo attuale $7.41

Basso$6.00 Media$13.93 Alto$21.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
ARVN	$753M	-10.4	-0.30%	-30.8%	-15.5%	·
ZVRA	$509M	6.6	350.9%	78.2%	61.2%	·
PHAT	$1.18B	-5.5	216.9%	-126.4%	52.4%	87.1%
AQST	$788M	-8.3	-22.6%	-188.1%	157.7%	·
EOLS	$432M	-8.3	11.6%	-17.4%	247.3%	66.3%
CTNM	·	-5.3	·	·	-27.7%	·
AVIR	$279M	-1.8	·	·	-49.5%	·
RLMD	$354M	-3.3	93.7%	·	-112.0%	·
TTRX	$116M	-32.8	·	·	-141.7%	·

Ultime notizie Notizie recenti che menzionano questa società

23

Rigel Pharma Firma Accordo di Licenza con Arvinas e Pfizer per Veppanu Nasdaq · 4 mesi, 3 settimane fa Arvinas entra in territorio di ipervenduto (ARVN) Nasdaq · 6 mesi, 1 settimana fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

ARVN Arvinas, Inc. - Common Stock